4.5 Letter

Circulating blood eosinophils as a biomarker for variable clinical presentation and therapeutic response in patients with chronic pruritus of unknown origin

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.jaip.2021.01.034

Keywords

-

Funding

  1. Pfizer
  2. Galderma
  3. Kiniksa Pharmaceuticals
  4. Dermatology Foundation Medical Dermatology Career Development Award

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available